Glabellar Frown Lines
59
1
2
50
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Published Results
24 trials with published results (41%)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 59 trials
100.0%
+13.4% vs benchmark
56%
33 trials in Phase 3/4
48%
24 of 50 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 50 completed trials
Clinical Trials (59)
Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for Glabellar Rhytides
Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines
A Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection (CU-20101)
Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines
Depth of Botulinum Neurotoxin Injection for Treatment of Glabellar Lines
AI-09 In Subjects With Glabellar Lines, GL-101
Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study III (BLESSIII)
A Non-inferiority Clinical Trial to Compare Efficacy and Safety of Abobotulinumtoxin A (Espad Pharmed) Versus AbobotulinumtoxinA (Dysport®, Ipsen Co.) for Correction of Moderate to Severe Glabellar Lines
Phase 2a Study of DaxibotulinumtoxinA-lanm for Injection in Dynamic Forehead Lines and Glabellar Lines
Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study I
Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study II
Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines
Efficacy of Zinc Supplementation on Botox Treated Forehead Rhytids
Study to Demonstrate Safety and Duration of Effect of 40 Units of PrabotulinumtoxinA-xvfs to Treat Glabellar Lines
The Efficacy and Safety of Protoxin in Subjects With Moderate to Severe Glabellar Lines
Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines
Study Comparing Treatment With Alluzience vs Reconstituted Toxin
Jeuveau Treatment of Glabellar Lines Using OLD Versus COLD
Long-term Extension Study to Evaluate MBA-P01 in Subjects With Moderate to Severe Glabellar Lines
Split-Face Study Comparing Botox and Jeuveau in Treating Glabellar Lines